✦ LIBER ✦

Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS

✍ Scribed by Fitian, Asem I.; Nelson, David R.; Liu, Chen; Xu, Yiling; Ararat, Miguel; Cabrera, Roniel

Book ID: 121815482
Publisher: John Wiley and Sons
Year: 2014
Tongue: English
Weight: 318 KB
Volume: 34
Category: Article
ISSN: 0106-9543
DOI: 10.1111/liv.12541

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

533 SELDI-TOF-MS profiling of serum for

533 SELDI-TOF-MS profiling of serum for detection of liver cirrhosis and hepatocellular carcinoma in chronic hepatitis C

✍ T. Göbel; S. Vorderwülbecke; K. Hauck; D. Häussinger; A. Erhardt 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 130 KB

SELDI-TOF-MS profiling of serum for dete

SELDI-TOF-MS profiling of serum for detection of hepatocellular carcinoma progression in hepatitis B and hepatitis C infected patients

✍ Richard R. Drake; Laura F. Steel; Bao-Ling Adam; Jorge Marrero; O.J. Semmes; Hie 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Untargeted Metabolomic Profiling in Sali

Untargeted Metabolomic Profiling in Saliva of Smokers and Nonsmokers by a Validated GC-TOF-MS Method

✍ Mueller, Daniel C.; Piller, Markus; Niessner, Reinhard; Scherer, Max; Scherer, G 📂 Article 📅 2014 🏛 American Chemical Society 🌐 English ⚖ 823 KB

Serum lipid profiling of patients with c

Serum lipid profiling of patients with chronic hepatitis B, cirrhosis, and hepatocellular carcinoma by ultra fast LC/IT-TOF MS

✍ Chen, Shili; Yin, Peiyuan; Zhao, Xinjie; Xing, Wenbin; Hu, Chunxiu; Zhou, Lina; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 1006 KB

SELDI-TOF MS profiling of serum for dete

SELDI-TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma

✍ E. Ellen Schwegler; Lisa Cazares; Laura F. Steel; Bao-Ling Adam; David A. Johnso 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 180 KB

Proteomic profiling of serum is an emerging technique to identify new biomarkers indicative of disease severity and progression. The objective of our study was to assess the use of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) to identify multiple serum